About Nanosyn
Nanosyn is a company based in Santa Clara (United States) founded in 1998 was acquired by Element Materials Technology in October 2021. Nanosyn has completed 1 acquisition, including Seres Laboratories. Nanosyn offers products and services including Custom Synthesis, Medicinal Chemistry, Analytical Services, API Process Research, and cGMP Manufacturing. Nanosyn operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nanosyn
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$295.3 K (USD), Grant
Jul 01, 2014
-
Investors
Element Materials Technology
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Element Materials Technology
(Oct 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanosyn
Nanosyn offers a comprehensive portfolio of products and services, including Custom Synthesis, Medicinal Chemistry, Analytical Services, API Process Research, and cGMP Manufacturing.
Service for synthesizing custom chemicals for drug research.
Designs and optimizes compounds for pharmaceutical applications.
Provides analysis and quality testing for drug compounds.
Develops processes for active pharmaceutical ingredients.
Offers compliant manufacturing for clinical and commercial use.
Funding Insights of Nanosyn
Investors in Nanosyn
Nanosyn has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Element Materials Technology and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Materials and product testing, inspection, and certification services are provided.
|
Locked | Locked | Locked |
Investor details for Nanosyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nanosyn
Nanosyn has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Seres Laboratories.
Investment portfolio details for Nanosyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Laboratory services and research are conducted in Santa Rosa.
|
Locked | Locked | 1977 | Locked |
Complete acquisition details for Nanosyn
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nanosyn
Detailed financials for Nanosyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanosyn Comparisons
Peer comparison for Nanosyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nanosyn
Nanosyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
Detailed competitors of Nanosyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanosyn
Complete news archive for Nanosyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanosyn
Nanosyn was founded in 1998 and raised its 1st funding round 15 years after it was founded.
Nanosyn is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Founded in 1998 and based in Santa Clara, United States, Nanosyn operates as a contract research organization in the drug discovery sector. Focused compound libraries, hit-to-lead optimization, and medicinal chemistry services are provided on demand. Chemistry operations encompass design, synthesis including process chemistry and cGMP manufacturing, and analytical services. Biology efforts include over 500 assays across targets like kinases and GPCRs, often utilizing a proprietary microfluidic platform.
Nanosyn's top competitors include Evotec, Crown Bioscience and NIH.
Nanosyn offers Custom Synthesis, Medicinal Chemistry, Analytical Services, API Process Research, and cGMP Manufacturing.
Nanosyn has made 1 acquisition, including Seres Laboratories.
Nanosyn has 2 investors. Key investors include Element Materials Technology, and HHS.